Beneficial role of the probiotic mixture Ultrabiotique on maintaining the integrity of intestinal mucosal barrier in DSS-induced experimental colitis. (June 2013)
- Record Type:
- Journal Article
- Title:
- Beneficial role of the probiotic mixture Ultrabiotique on maintaining the integrity of intestinal mucosal barrier in DSS-induced experimental colitis. (June 2013)
- Main Title:
- Beneficial role of the probiotic mixture Ultrabiotique on maintaining the integrity of intestinal mucosal barrier in DSS-induced experimental colitis
- Authors:
- Toumi, Ryma
Abdelouhab, Katia
Rafa, Hayet
Soufli, Imene
Raissi-Kerboua, Djamila
Djeraba, Zineb
Touil-Boukoffa, Chafia - Abstract:
- <abstract> <title>Abstract</title> <p>The etiology of inflammatory bowel diseases which include ulcerative colitis (UC) and Crohn disease has not yet been clarified. Several hypotheses suggest a change in composition of gut microflora along with an impaired mucosal barrier that lead to excessive mucosal immunologic responses. Increased production of nitric oxide (NO) contributes greatly to the tissue injury caused by chronic inflammation. Evidence indicates that the mucus layer covering the epithelium is altered during UC and experimental colitis. Our aim in this study was to investigate the potential therapeutic effect of probiotic during DSS-induced colitis by modulating the immune system and colonic mucus production. For that purpose, the probiotic formulation Ultrabiotique® (<italic>Lactobacillus acidophilus, Bifidobacterium lactis, Lactobacillus plantarum</italic> and <italic>Bifidobacterium breve</italic>) was administered daily for 7 d to mice with colitis. Probiotic supplementation improved clinical symptoms and histological alterations observed during DSS induced colitis. Ultrabiotique® treatment down regulated the NO production by peritoneal macrophages of DSS-treated mice and enhanced mucus production in both DSS-treated and healthy mice. In conclusion, the modification of microflora by the Ultrabiotique® played a beneficial role in maintaining the integrity of the intestinal mucosal barrier and promoted tissue repair.</p> </abstract>
- Is Part Of:
- Immunopharmacology and immunotoxicology. Volume 35:Number 3(2013:Jun.)
- Journal:
- Immunopharmacology and immunotoxicology
- Issue:
- Volume 35:Number 3(2013:Jun.)
- Issue Display:
- Volume 35, Issue 3 (2013)
- Year:
- 2013
- Volume:
- 35
- Issue:
- 3
- Issue Sort Value:
- 2013-0035-0003-0000
- Page Start:
- 403
- Page End:
- 409
- Publication Date:
- 2013-06
- Subjects:
- Immunopharmacology -- Periodicals
Immunotoxicology -- Periodicals
Antibody-toxin conjugates -- Periodicals
Immunology -- Periodicals
615.37 - Journal URLs:
- http://informahealthcare.com/journal/ipi ↗
http://informahealthcare.com ↗ - DOI:
- 10.3109/08923973.2013.790413 ↗
- Languages:
- English
- ISSNs:
- 0892-3973
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4369.760200
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 4088.xml